Alfredo Bardají Ruiz-rekin lankidetzan egindako argitalpenak (9)

2021

  1. Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615

  2. COVID-19 and the impact of arterial hypertension—An analysis of the international HOPE COVID-19 Registry (Italy-Spain-Germany)

    European Journal of Clinical Investigation, Vol. 51, Núm. 11

  3. Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry

    Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966

  4. Underlying heart diseases and acute covid-19 outcomes

    Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214

2020

  1. Impact of renal function on admission in COVID-19 patients: an analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID 19) Registry

    Journal of Nephrology, Vol. 33, Núm. 4, pp. 737-745

2016

  1. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

2009

  1. Risk Stratification of Mortality in Patients With Heart Failure and Left Ventricular Ejection Fraction >35%

    American Journal of Cardiology, Vol. 103, Núm. 7, pp. 1003-1010

2008

  1. Association of Blood Pressure and Its Evolving Changes With the Survival of Patients With Heart Failure

    Journal of Cardiac Failure, Vol. 14, Núm. 7, pp. 561-568

2007

  1. Left atrial enlargement and NT-proBNP as predictors of sudden cardiac death in patients with heart failure

    European Journal of Heart Failure, Vol. 9, Núm. 8, pp. 802-807